After DOD Award, Datlof Looks to Future of Military Medical Technology Transfer
January 30, 2025
FORT DETRICK, Md. – For 25 years, the Office of Medical Technology Transfer has worked with inventors, businesses and investors to commercialize and deliver dozens of innovative life-saving devices and medicines for the Warfighter and the public. The heart of MTT’s success is an award-winning process for systematically maturing and de-risking first-generation biomedical technologies called Assistive Technology Transfer, or AT2. For his contributions to developing and implementing AT2, Barry Datlof, MTT’s chief of business development and commercialization, recently received the 2024 Department of Defense George F. Linsteadt Technology Transfer Achievement Award from the Office of the Under Secretary of Defense for Research and Engineering.